YIDU TECH (02158) has bought back nearly 3.2 million shares four times in half a month, costing approximately 18.6 million Hong Kong dollars.
Medical Journey Technology announced that since September 26, the company has conducted a total of 4 buybacks, repurchasing a total of 3.1916 million shares with a total repurchase amount of 18.6359 million Hong Kong dollars.
YIDU TECH (02158) announced that on October 14, it repurchased 147.28 million shares at a price of HK $5.75-5.99 per share, with a total repurchase amount of HK $8.58 million. Since September 26, the company has conducted a total of 4 repurchases, repurchasing a total of 3.19 million shares, with a cumulative repurchase amount of HK $18.64 million.
In recent news, the world's first topical treatment gel for superficial infantile hemangiomas in the proliferative phase - malysilol gel has been approved for listing. YIDU TECH provides key market research and project research analysis services, which have provided important support for the development and listing of drugs.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


